Clinical Trials Browser

Phase 1 × INDUSTRY × relmacabtagene autoleucel × Clear all

NCT05259813 2023-11-24

Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04812691 2023-11-22

CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse